Why our steriles early development solutions help reach the patient quicker.

The rapid 10 percent growth of sterile drug product over the past 5 years is being aided by the rise in biologics, orphan drugs, oncology, therapeutics, as well as other environmental factors. As a result, Thermo Fisher Scientific understands the critical need for robust and flexible early development solutions, so you can:

  • Overcome complex formulation challenges: solubility, stability, process
  • Build a robust process development program
  • Navigate a complex regulatory environment (IND, filing, etc.)
  • Build success in early development to enable commercial success
  • Shorten timelines to get to market quicker

Why Thermo Fisher Scientific’s Steriles Commercial Manufacturing solutions optimizes your chances of approval?

Scaling to commercial manufacturing can be arduous as you try to balance speed, regulatory and the supply chain. Thermo Fisher Scientific offers experience, reliability, and a broad range of sterile fill/finish commercial solutions that enable you to:

mysupply Platform

An end-to-end digital supply chain platform that provides visibility and collaboration across the full product lifecycle

From development to launch, pharma products navigate a dynamic global supply chain with potential changes and delays. To manage these changes, pharmaceutical companies go to great lengths to understand the status of production, mitigate risk, and proactively forecast. With integrated data sources, smart analytics, and a collaboration-first approach, mysupply Platform drives attention to where it matters most.

Already using the mysupply Platform? Login here.

Download our Sterile Dose Form brochure.

Related Sites

Additional Resources